inflammation and disease

Upload: mday83

Post on 04-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/13/2019 Inflammation and Disease

    1/43

    INFLAMMATION &

    DISEASEJessica Nagelkirk, NDSeptember 27, 2013

    Marquette General Hospital

    Nutrition and Medicine Conference

  • 8/13/2019 Inflammation and Disease

    2/43

    Disclosures

  • 8/13/2019 Inflammation and Disease

    3/43

    Wait, youre an ND not an MD?

    Naturopathic physicians are primary care providers who

    have graduated from an accredited 4-year medical school

    after obtaining a bachelor degree that includes pre-

    medicine studies. Complete nearly identical training in the basic sciences,

    physical, laboratory, and imaging diagnostics,

    pharmacology, and minor surgery procedures as

    conventional medical school. Pass a national board examination comparable to the

    USMLE step 1, 2, and 3 board examination.

    Complete a residency program in family medicine.

  • 8/13/2019 Inflammation and Disease

    4/43

    In addition to conventional training

    Naturopathic physicians are experts in the use of

    Nutritional IV Therapy

    Clinical Nutrition

    Botanical Medicine

    Lifestyle Counseling

    Environmental Medicine

    Physical Medicine

    Hydrotherapy

    Homeopathy

  • 8/13/2019 Inflammation and Disease

    5/43

  • 8/13/2019 Inflammation and Disease

    6/43

    Prasad S, et al. Age-associated chronic disease required age-old medicine: chronic ifnlammation. Prev Med. 2012 May; 54

  • 8/13/2019 Inflammation and Disease

    7/43

    Inflammation and Disease

    Inflammation occurs by both immune and non-immune

    mediated mechanisms.

    Both pathways lead to the production of reactive oxygenspecies (ROS), that alter cell metabolism, genes, and

    epigenetics.

    This sustained inflammatory/oxidative environment leadsto a vicious cycle eventually moving from physiologic

    dysfunction to true physical pathology.

  • 8/13/2019 Inflammation and Disease

    8/43

    Immune Mediated Mechanism

  • 8/13/2019 Inflammation and Disease

    9/43

    Phospholipid/ Non-Immune Mechanisms

    Linoleic Acid Arachidonic Acid Alpha-Linoleinic Acid

    From plant based omega-6 fatty

    acids like nuts, seeds, grains,

    etc

    From animal based omega-6

    fatty acids

    From fish and plant based

    omega-3 fatty acids like flax

    GLAEPAFound in borage, black currant,

    evening primrose, human milk

    Leukotrienes PGE2

    COX I & II

    5-lipoxygenase

    DHA

    PGE3

    PGE1

    Delta-5 Desaturase

    Delta-6 Desaturase

    Delta-6 Desaturase

    Note: Some people are deficient in delta-6 desaturase, an

    enzyme promoted by vitamin B3, B6, Mn, C, E and inhibited

    by alcohol and stress.

    DGLA

  • 8/13/2019 Inflammation and Disease

    10/43

    Inflammation and Alterations

    Gastroenterology 2012; 143:550-563 (DOI:10.1053/j.gastro.2012.07.009 )

  • 8/13/2019 Inflammation and Disease

    11/43

    ROS-Linked Pathology

    Diseases

    Acute respiratory distress syndrome

    Aging

    Alzheimer

    Atherosclerosis

    Cardiovascular disease

    Diabetes

    Inflammation

    Inflammatory joint disease

    Neurological disease

    Obesity Parkinson

    Pulmonary fibrosis

    Rheumatoid arthritis

    Vascular disease

    Cancer

    Bladder

    Brain

    Breast

    Cervical (secondary to HPV) Gastric

    Liver

    Lung

    Melanoma

    Multiple myeloma

    Leukemia

    Lymphoma Oral

    Ovarian

    Pancreatic

    Prostate

    sarcoma

    Simone R, et al. Oxidative Stress, inflammation, & Cancer. Free Radical Biology and Medicine 2010

  • 8/13/2019 Inflammation and Disease

    12/43

    Daily Aspirin

    Aspirin is the acetylated form of salicylic acid.

    It inhibits prostaglandin synthesis decreasing

    inflammation but also causes GI bleeding.

    Data concerning colorectal cancer has become verycompelling with regard to aspirins capacity to prevent

    primary disease.

    Recent data from multiple trials suggest that long-term

    daily use of aspirin lowers risk for colorectal cancer.

    Chronic inflammation has been linked to heart disease,

    neurological disorders and cancer.

  • 8/13/2019 Inflammation and Disease

    13/43

    Aspirin

    Aspirin inhibits

    cyclooxygenase

    (COX)-1.

    It also acetylatesCOX-2 turning

    arachidonic acid

    into the

    intermediate 15-R-HETE which is

    transformed into the

    anti-inflammatory

    ALT by neutrophils.

    http://archives.focus.hms.harvard.edu/2004/Oct15_2004/anesthesia.html

  • 8/13/2019 Inflammation and Disease

    14/43

    Aspirin and White Willow Bark (Salix alba)

    Salix alba is considered to be the natural form and original

    source of the modern aspirin.

    Contains phenolic glycosides salicin and salicylic acid

    It is the acetylation process of aspirin that allows it to act

    on the COX-2 pathway decreasing inflammation.

    White Willow Bark and other salicylate-containing herbs

    are anti-inflammatory without danger to the stomach, but

    do not utilize the same COX-2 pathway mechanism,

    instead it down regulates COX expression.

  • 8/13/2019 Inflammation and Disease

    15/43

    Anti-inflammatory Plant Constituents

    Cyclooxygenase Inhibitors Flavonoids

    Phenolic Phenylpropane derivatives

    Naphthoquinones

    Akyl amides Tannins

    5-Lipoxygenase Inhibitors Phenolic structures

    Arachidonic acid analogs

    Long-chain unsaturated fatty acids

    PAF Inhibitors Ginkgolides

    Lignans and neolignans

  • 8/13/2019 Inflammation and Disease

    16/43

    Plants Containing Steroid Precursors

    Examples:

    Glycyrrhiza gabrra

    (Licorice)

    Dioscorea villosa (Wild

    Yam)

    Most useful for auto-immune inflammation

  • 8/13/2019 Inflammation and Disease

    17/43

    Essential Oil-Rich Plants

    Examples: Matricaria recutita

    (Chamomile)

    Calendula officinalis

    (Calendula) Hypericum perforatum (St.

    Johns Wort)

    Effective for digestivesystem inflammationwith taken PO. Effectivefor skin inflammationwhen used topically.

  • 8/13/2019 Inflammation and Disease

    18/43

    Histamine Blocking

    Examples:

    Tanacetum parthenium

    (Feverfew)

    Scutellariabailcalensis(Chinese

    Skullcap)

    Ginkgo Biloba

  • 8/13/2019 Inflammation and Disease

    19/43

    Inflammatory Enzyme Modulating

    PhosphodiesteraseInhibitors Camellia sinensis (tansy)

    Berberis (Oregon Grape)

    Lipoxygenase Inhibitors Quercitin containing herbs

    like Nettles

    Cyclooxygenase

    Inhibitors Salicylate containing herbs

    like Betula (birch), Populus(Poplar), or Gaultheria(Wintergreen)

  • 8/13/2019 Inflammation and Disease

    20/43

    Other Types

    Many herbs seem to act in anti-inflammatory fashion but

    have no known chemical anti-inflammatory component.

    Coleus orskholii, Bupleurum, Tanacetum parthenium, Zingiber officinalis, Glycyrrhizaglabra, Scutellaria bicalensis, Panax ginseng, Crataegus oxyacantha, Zizphus, Asarum,

    nidium, Phellodendron, Copis aponica, Allium cepa, Picrorrhiza kurroa, Tylophora

    asthmatica, Capsella bursa, Ginkgo biloba, Camellia sinensis, Berberis, Schisandra,

    Magnolia, Curcuma longa, Ananas comosus, Calendula officinalis, Matricaria spp,

    Ficus elastica, Hypericum perforatum, Arnica montana, Vaccinium myrtillis, Silybum

    marianum, Betula, Salix, Populis, Filipendula, Gaultheria, Spirea, Cimicifuga, Linumussitatissimum, Borago, Ribes, Onethera, Smilax, Yucca, Centella, Hemidesmmus,

    Ganoderma, Coleus, Eleuthrococcus, Aloe vera, Lentinus, Chlorella, Cinnamomum,

    Artemesia, Lavendula, Apium graveolens, Carica papaya, Eugenia, Commiphora

    mukul, Angelica sinensis

  • 8/13/2019 Inflammation and Disease

    21/43

    Turmeric (Curcuma longa)

  • 8/13/2019 Inflammation and Disease

    22/43

    Turmeric

    Effects

    Anti-inflammatory

    Antiplatelet aggregation

    Antioxidant

    Antimicrobial

    Inhibits carcinogenesis

    Carminative

    Key Constituents

    Essential Oil containing

    sesquiterpene ketones,

    zingiberene,phellandrene, sabinene,

    cineole, and borneol

    Yellow pigments known

    as diarylheptanoids

    including curcuminand

    methoxylated curcumins

  • 8/13/2019 Inflammation and Disease

    23/43

    Pharmacodynamics of Turmeric

    Curcuminappears to undergo rapid biotransformation

    during and after gastrointestinal absorption.

    It has been found that 40-85% of an oral dose of curcumin

    passes through the gastrointestinal tract unchanged.

    Due to its low rate of absorption, it is often formulated

    with bromelain and black pepper for increased absorption

    as well as enhanced anti-inflammatory effects.

    C l h N t l M di i C h i D t b

  • 8/13/2019 Inflammation and Disease

    24/43

    Anti-inflammatory Activity of Turmeric

    The anti-inflammatory activity of curcuminwas reported as farback as 1937. In an extension of this work, it was reported that oral doses of

    curcuminpossess significant anti-inflammatory action in both acuteand chronic models.

    MOA: Dual inhibitor of arachidonic acid metabolism viamodulation of COX-2, prostaglandins, leukotrienes, and othercytokine pathways in the pro-inflammatory signaling pathway.

    Dual inhibitors of AA are attracting interest as anti-inflammatoryagents since they prevent potentially damaging effects ofincreased leukotriene production which can result from the useof only COX inhibitors such as aspirin.

    Curcuma longa monograph. Natural Medicines Comprehensive Database

  • 8/13/2019 Inflammation and Disease

    25/43

    Evidence Based Medicine

    A search for Curcuma longa and inflammation on PubMed

    yielded 162 results.

    Are Curcuminoids Effective C-Reactive Protein-Lowering

    Agents in Clinical Practice? Evidence from a Meta-Analysis.Phytother Res.2013 Aug 7. doi:10.1002/ptr.5045.

    This meta-analysis found that ingestion of curcuminoids

    significantly decreased CRP levels. The degree of effect was

    dependent on bioavailability of curcuminoid compounds used

    and the duration of use. The highest yield was amongst subject

    ingestion a bio-availability improved curcuminoid for greater

    than or equal to 4 weeks.

    http://www.ncbi.nlm.nih.gov/pubmed/23922235http://www.ncbi.nlm.nih.gov/pubmed/23922235
  • 8/13/2019 Inflammation and Disease

    26/43

    Evidence Based Medicine

    Immune-stimulatory and anti-inflammatory activities ofCurcuma longa extract and its polysaccharide fraction.Pharmacognosy Res.2013 Apr;5(2):71-9. doi: 10.4103/0974-8490.110527.Chandrasekaran CV, Sundarajan K, Edwin JR, Gururaja GM, MundkinajedduD,Agarwal A.

    This study demonstrated that an aqueous solution ofcurcuma longa, devoid of curcuminoids, continued topossess anti-inflammatory qualities. This solutionappeared to inhibit IL-12 and PGE2 in vitro.

    This study highlights the complexity of herbal therapeuticaction. Even when we identify a therapeutic action, thesynergistic action of the whole plant is often morecomplex.

    http://www.ncbi.nlm.nih.gov/pubmed/23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Chandrasekaran%20CV[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Sundarajan%20K[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Edwin%20JR[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Gururaja%20GM[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Agarwal%20A[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Agarwal%20A[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Mundkinajeddu%20D[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Gururaja%20GM[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Edwin%20JR[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Sundarajan%20K[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed?term=Chandrasekaran%20CV[Author]&cauthor=true&cauthor_uid=23798880http://www.ncbi.nlm.nih.gov/pubmed/23798880
  • 8/13/2019 Inflammation and Disease

    27/43

    Evidence Based Medicine

    Curcumin: an orally bioavailable blocker of TNF andother pro-inflammatory biomarkers. Br J Pharmacol.2013Aug;169(8):1672-92. doi: 10.1111/bph.12131.Aggarwal BB, Gupta SC,Sung B.

    This meta-analysis examines curcuma longas effects onTNF and discusses its role as an adjunct or substitute topharmacologic TNF blockers.

    This analysis references studies from as early as 1937

    demonstrating efficacy of turmeric in treating inflammatorydiseases in patients.

    There are studies documenting curcuminsefficacy intreating many inflammatory diseases includingrheumatoid arthritis, IBD, many cancers, diabetes, andheart disease.

    http://www.ncbi.nlm.nih.gov/pubmed/23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Aggarwal%20BB[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Gupta%20SC[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Sung%20B[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Sung%20B[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Gupta%20SC[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed?term=Aggarwal%20BB[Author]&cauthor=true&cauthor_uid=23425071http://www.ncbi.nlm.nih.gov/pubmed/23425071
  • 8/13/2019 Inflammation and Disease

    28/43

    Evidence Based Medicine

    Comparative evaluation of the pain-relieving properties of alecithinized formulation of curcumin (Meriva()), nimesulide, andacetaminophen.J Pain Res.2013;6:201-5. doi: 10.2147/JPR.S42184. Epub 2013 Mar 8.Di Pierro F, Rapacioli G, Di Maio EA,Appendino G, Franceschi F, Togni S.

    This pilot study investigated the acute analgesic activity of the curcumin

    derivative Meriva. Meriva was compared to nimesulide and acetaminophen and

    demonstrated an effect comparable to acetaminophen but less thannimesulide. Meriva was more well tolerated than nimesulide andcomparable to nimesulide. Meriva was utilized at a larger dose than forchronic inflammation (2 g vs 500 mg) in order to achieve this acuteanalgesic effect.

    The effect is thought to stem from COX 2 inhibition and desensitization ofreceptor potential A1 (a receptor that also mediates the analgesic effectsof acetaminophen). Additionally, the authors speculate that the long termattenuation of inflammation from the acute supplementation of Merivawould lead to better control of acute pain.

    Mills S, Bone K. Principles & Practice of Phytotherapy

    http://www.ncbi.nlm.nih.gov/pubmed/23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Pierro%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Rapacioli%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Maio%20EA[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Appendino%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Franceschi%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Togni%20S[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Togni%20S[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Franceschi%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Appendino%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Maio%20EA[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Rapacioli%20G[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed?term=Di%20Pierro%20F[Author]&cauthor=true&cauthor_uid=23526055http://www.ncbi.nlm.nih.gov/pubmed/23526055
  • 8/13/2019 Inflammation and Disease

    29/43

    Turmeric in Clinical Practice

    Preparations: Dried root may be used as a decoction; liquid extract, or capsules.

    Dosage:

    Powdered rhizome provided at a heaped teaspoon (about 4 grams)mixed with water to a slurry and drank 1-2 times daily. A teaspoon oflecithin can be added to improve absorption.

    1:1 liquid extract using 45% ethanol or higher recommended at 5-14ml per day best taken in 4 equal doses throughout the day

    Encapsulated common sig is 500 mg QID

    Duration of use & safety: May be taken long term within the recommended dosages. No

    adverse effects from ingestion of turmeric have been documented atthe recommended dosages.

    Mills S, Bone K. Principles & Practice of Phytotherapy

  • 8/13/2019 Inflammation and Disease

    30/43

    Omega-3 Fatty Acids

  • 8/13/2019 Inflammation and Disease

    31/43

    Eicosanoids & Inflammation

    Eicosanoids are signaling molecules made byoxygenation of 20-carbon PUFAs

    Metabolism product of COX and LOX enzymes

    Modulate:

    Cell growth and differentiation Intensity and duration of inflammatory response

    Immunity

    Platelet Aggregation

    Angiogenesis

    Include: Prostaglandins (PG)

    Thromboxanes (TX)

    Leukotrienes (LT)

  • 8/13/2019 Inflammation and Disease

    32/43

    EPA and DHA

    >15,000 studies

    published in past 40

    years on health

    benefits of EPA & DHA

    EPA and DHA are

    natural COX-2

    inhibitors

  • 8/13/2019 Inflammation and Disease

    33/43

    Conversion Pathway of Omega-3 FA

    Alpha-Linolenic Acid (ALA)18:3n-3

    Stearidonic Acid

    18:4n-3

    Eicosatetraenoic Acid20:4n-3

    Eicosapentaenoic Acid (EPA)

    20:5n-3

    Docosapentaenoic Acid (DPA)

    22:5n-3

    Docosahexaenoic Acid (DHA)

    22:6n-3

    Anti-Inflammatory

    Resolvins & Protectins

    Flax, hemp, canola oilsand walnuts

    Hemp, modified

    vegetable oils, fish

    Fish, Fish Oil

    Fish, Fish Oil, Algae

    6-desaturaseCofactors: B3, B6, Mg, Zn Vit C

    Inhibited: alcohol, trans fats,

    diabetes, hyperinsulinemia

    Dong-Soon IM. Omega-3 fatty acids in anti-inflammation on GPCRs. Progress in Lipid Research. July 2012. 51(3):232-237

  • 8/13/2019 Inflammation and Disease

    34/43

    Resolvins & Protectins

    Anti-inflammatory actions that lead to the resolution ofthe inflammatory cycle

    Experimental evidence indicates that resolvins and

    protectins reduce cellular inflammation by stoppingexcessive neutrophil infiltration and clearing apoptoticPMN leukocytes from sites of inflammation

    They are synthesized from either eicosapentaenoic acid(EPA) or docosahexaenoic acid (DHA)

    Both series of resolvins (E and D) increase with use oflow dose aspirin or supplementation with EPA/DHA

    g g y g p y ( )

  • 8/13/2019 Inflammation and Disease

    35/43

    Evidence Based Medicine

    N-3 polyunsatruated fatty acids: relationship to

    inflammation in healthy adults and adults exhibiting

    features of metabolic syndrome.

    Robinson LE, Mazurak VC. Lipids. 2014 Apr;48(4)319-32.

    This review article supports the recommendation that a diet

    rich in omega-3 fatty acids plays a role in the prevention

    and reduction of inflammation.

  • 8/13/2019 Inflammation and Disease

    36/43

    Evidence Based Medicine

    Omega-3 fatty acids and inflammatory processes.

    Calder PC. Nutrients. 2010 Mar;2(3);355-74

    This review article evaluated the mechanisms in which EPA

    and DHA modulate inflammation in which they concluded a

    variety of mechanisms were involved. Anti-inflammatory

    actions of marine n-3 PUFAs were specifically identified to

    be useful in inflammatory conditions including RA and

    atherosclerosis, however the authors speculate n-3 PUFAswould be useful in nearly all inflammatory conditions due to

    the known MOA.

    Williams CM, Burdge G. Long-chain n-3 PUFA: Plant v. marine sources. Proc Nutr Soc. 2006 Feb; 65(1):42-50

  • 8/13/2019 Inflammation and Disease

    37/43

    Is Conversion of ALA to LCPUFA

    Efficient?

    ALA

    18:3n-3

    EPA

    20:5n-3

    DPA

    22:5n-3

    DHA

    22:6n-3

    0.2-8% Conversion

    0.13-6% Conversion

    Trace- 0.5% Conversion

    An intake of 2 grams

    of ALA would yield

    approximately 160mg EPA at a

    conversion rate of

    8% and

    approximately 10 mg

    DHA at a conversion

    rate of 0.5%.

  • 8/13/2019 Inflammation and Disease

    38/43

    Omega-3 as Inflammatory Modulator in

    Clinical Practice Ratio

    1:2 EPA:DHA

    Dose

    3 grams EPA+DHA po qd

    Reference

    Health Canada

    Warning: Make sure to have your patients purchase

    products that undergo third party testing for purity and

    content.

    Giugliano D, et al. The effects of diet on inflammation. Journal of Amer Col Card. 2006. 48(4)

  • 8/13/2019 Inflammation and Disease

    39/43

    Anti-Inflammatory Diet

    Low consumption of fruit and vegetables, together with physical inactivity, are

    now among the top 10 causes of mortality in developed countries.

  • 8/13/2019 Inflammation and Disease

    40/43

    What is an anti-inflammatory diet?

    It depends who you ask.

    Several different versions, that all have the same basic

    guidelines:

    Increase omega-3 fatty acids

    Increase anti-oxidants

    Decrease processed foods

    Decrease alcohol and caffeine

    Eliminate known allergens

    Eliminate sugar

    Some guidelines go further and eliminate:

    Nightshade vegetables (potato, tomato, eggplant, bell peppers etc.)

    Common allergens like soy, peanuts, gluten, dairy, & eggs

    Sears B, Ricordi C. Anti-inflammatory nutrition as a pharmacological approach to treat obesity. J Obes. 2011

  • 8/13/2019 Inflammation and Disease

    41/43

    MOA of Diet and Inflammation

    Dietary intake of arachidonic acid up-regulates

    prostaglandin synthesis.

    Increased prostaglandin and inflammation leads to insulin

    resistance and lipid oxidation.

    This leads to increases in silent inflammation and

    obesity.

    Greater intake of antioxidant containing foods reduces

    inflammatory cytokines and mitigates this process.

  • 8/13/2019 Inflammation and Disease

    42/43

    Inflammation and Disease

    Inflammation has been implicated in many chronic

    diseases.

    There are many ways to decrease inflammation through

    diet and lifestyle.

    Herbs and fish oil are a helpful adjunct to these

    interventions.

    By addressing inf lammation as a preventive measure,

    we can work towards in creasing qual i ty of l i fe and

    decreasing morbid i ty and mortali ty in ou r pat ients.

  • 8/13/2019 Inflammation and Disease

    43/43

    Contact Information

    [email protected]

    503-552-1874

    mailto:[email protected]:[email protected]